Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
NCT00094107
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Skin Neoplasms
Interventions
DRUG:
Axitinib [AG-013736]
Sponsor
Pfizer